🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 122,22 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 148,73 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 2 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 14/09/2022 | 0,6900 USD |
| 14/06/2022 | 0,6900 USD |
| 14/03/2022 | 0,6900 USD |
| 14/12/2021 | 0,6900 USD |
| 14/09/2021 | 0,6500 USD |
| 14/06/2021 | 0,6500 USD |
| 12/03/2021 | 0,6202 USD |
| 14/12/2020 | 0,6202 USD |
| 14/09/2020 | 0,5821 USD |
| 12/06/2020 | 0,5821 USD |
| 13/03/2020 | 0,5821 USD |
| 13/12/2019 | 0,5821 USD |
| 13/09/2019 | 0,5248 USD |
| 14/06/2019 | 0,5248 USD |
| 14/03/2019 | 0,5248 USD |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 09/02/2015 | 55,96 | 56,30 | 55,28 | 55,66 | -0,78% | 1,82% | 10.494.777 |
| 06/02/2015 | 56,39 | 57,03 | 55,90 | 56,10 | -0,64% | 2,01% | 10.338.310 |
| 05/02/2015 | 56,56 | 56,63 | 55,83 | 56,46 | +0,20% | 1,42% | 13.268.099 |
| 04/02/2015 | 57,22 | 57,25 | 55,67 | 56,35 | -3,23% | 2,77% | 20.380.142 |
| 03/02/2015 | 58,10 | 58,26 | 57,19 | 58,23 | +0,23% | 1,84% | 12.028.420 |
| 02/02/2015 | 57,73 | 58,14 | 57,04 | 58,09 | +1,00% | 1,90% | 9.711.502 |
| 30/01/2015 | 58,71 | 59,09 | 57,28 | 57,52 | -2,92% | 3,09% | 12.667.071 |
| 29/01/2015 | 58,72 | 59,30 | 57,98 | 59,25 | +1,04% | 2,26% | 9.527.682 |
| 28/01/2015 | 59,94 | 60,08 | 58,51 | 58,64 | -1,77% | 2,61% | 9.293.769 |
| 27/01/2015 | 60,00 | 60,13 | 59,28 | 59,69 | -0,41% | 1,42% | 8.347.425 |
| 26/01/2015 | 59,71 | 60,10 | 59,27 | 59,94 | +0,53% | 1,37% | 7.036.901 |
| 23/01/2015 | 59,60 | 60,11 | 59,55 | 59,63 | -0,16% | 0,94% | 6.528.097 |
| 22/01/2015 | 59,41 | 59,84 | 58,71 | 59,72 | +0,69% | 1,90% | 8.902.131 |
| 21/01/2015 | 59,56 | 59,90 | 59,24 | 59,31 | -0,72% | 1,12% | 9.517.307 |
| 20/01/2015 | 59,84 | 60,40 | 59,05 | 59,74 | -0,67% | 2,26% | 13.734.983 |
| 16/01/2015 | 59,03 | 60,27 | 58,71 | 60,14 | +1,86% | 2,64% | 11.917.018 |
| 15/01/2015 | 59,91 | 60,11 | 59,00 | 59,05 | -1,21% | 1,85% | 10.023.701 |
| 14/01/2015 | 58,89 | 60,03 | 58,66 | 59,77 | +0,72% | 2,32% | 10.331.289 |
| 13/01/2015 | 60,03 | 60,71 | 58,90 | 59,34 | -0,18% | 3,00% | 10.516.890 |
| 12/01/2015 | 60,21 | 60,59 | 59,26 | 59,45 | -0,42% | 2,22% | 12.124.312 |
| 09/01/2015 | 59,93 | 60,24 | 59,32 | 59,69 | -0,46% | 1,53% | 13.245.358 |
| 08/01/2015 | 59,16 | 60,06 | 59,02 | 59,97 | +2,01% | 1,76% | 20.038.808 |
| 07/01/2015 | 57,67 | 58,80 | 57,60 | 58,79 | +2,14% | 2,08% | 19.528.956 |
| 06/01/2015 | 55,61 | 57,73 | 55,58 | 57,56 | +3,93% | 3,86% | 25.453.510 |
| 05/01/2015 | 55,54 | 55,80 | 54,93 | 55,38 | +1,49% | 1,56% | 16.727.338 |
| 02/01/2015 | 54,60 | 55,14 | 54,42 | 54,57 | +0,70% | 1,33% | 7.415.962 |
| 31/12/2014 | 54,65 | 55,20 | 54,13 | 54,19 | -1,49% | 1,96% | 7.842.813 |
| 30/12/2014 | 54,90 | 55,12 | 54,68 | 55,01 | -0,14% | 0,82% | 5.486.070 |
| 29/12/2014 | 54,82 | 55,27 | 54,82 | 55,09 | -0,09% | 0,82% | 6.291.982 |
| 26/12/2014 | 55,04 | 55,36 | 54,95 | 55,13 | +0,56% | 0,75% | 4.897.094 |